Crescentis Capital Limited submitted a prior intimation to BSE Limited's Corporate Relations Department regarding an upcoming board meeting scheduled for Tuesday, November 3, 2026. The meeting is being convened specifically to approve documentation for a Rights Issue of equity shares.
The primary agenda items for the board meeting include:
- Approval of the Letter of Offer, Composite Application Form, and Rights Entitlement letter to be sent to Eligible Equity Shareholders
- Finalization of terms and conditions for the Rights Issue, including issue price, payment mechanism, issue size, rights entitlement ratio, and record date
This meeting follows the company's previous disclosure regarding the board meeting held on September 30, 2026, where the board initially approved raising funds through a rights issue of equity shares with a face value of ₹10 each for an amount up to ₹80 crores.
The company also noted that BSE Limited has granted in-principle approval for listing the fully paid-up equity shares to be issued through the rights basis, as communicated via letter reference number LOD/RIGHT/MV/1005/2026-27 dated October 23, 2026.
Additionally, the trading window for designated persons and their immediate relatives has been closed since October 1, 2026, in connection with the consideration and declaration of the company's Unaudited Financial Results for the quarter and half year ending September 30, 2026. This closure was previously intimated to BSE Limited via the company's letter dated September 23, 2026.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.